We focus on the discovery and development of novel therapeutic proteins through a variety of collaboration frameworks.
Our mission is to vastly accelerate the process of therapeutic protein discovery by designing radically novel molecules to achieve specific and potent pharmacological activity.
Our core values are reduction of environmental impact and health equity. We assist and collaborate with partners to explore the use of peptides and proteins for metal binding and other ways to recycle metals and other contaminants. Our human therapeutics focus on developing biomimics with similar or improved biological activity. We aim to simultaneously build special requirements into our products, for example, therapeutic cytokines that are thermostable to 100 degrees Celsius so that these proteins can be used in locations lacking reliable refrigeration.
Computational Capacity
Our core technologies are based on a set of computational design algorithms that enable us to create guided molecular interactions and build architectures at atomic precision.
Experimental Capacity
We experimentally characterise the biophysical properties, atomic structure, and pharmacological activity of our designs in an expedited pipeline, allowing fast arrival at pre-clinical candidates.